Evaluation of the 5-year review of negative cervical smears in patients with high grade squamous intraepithelial lesions.
Federal regulations require laboratories to re-examine negative cervical smears from the 5 yr preceding a diagnosis of high-grade squamous intraepithelial lesion (HSIL) or carcinoma. To assess the value of this regulation as a quality assurance measure, we evaluated the previous cervical smears from 47 patients with a diagnosis of HSIL rendered during a 9-mo period. Fifteen patients had a total of 24 previous smears initially reported as squamous intraepithelial lesions (SIL). The remaining 32 patients had a total of 58 smears that carried a diagnosis lesser than SIL. Upon re-screening 22/58 (38%) smears, from 16 patients, were upgraded to SIL (8 low grade, 14 high grade). Underdiagnosed SIL was detected in seven (44%) patients with the 1-yr review, 12 (75%) with the 2-yr review, 15 (94%) with the 3-yr review, and 16 (100%) with the 5-yr review. The authors conclude that the negative smear review is a beneficial quality assurance and teaching method that may lead to quality improvement. A 3-yr retrospective review is effective and detects 94% of the undercalls.
Tabbara
S O
SO
Department of Pathology, George Washington University Medical Center, Washington, D.C., USA.
Sidawy
M K
MK
D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000517:prevention & control; D002584:Cervix Uteri / Q000473:pathology; D003951:Diagnostic Errors / Q000706:statistics & numerical data; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000331:legislation & jurisprudence / Q000592:standards*; D010338:Pathology, Clinical / Q000331:legislation & jurisprudence / Q000592:standards; D011786:Quality Control; D012189:Retrospective Studies; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000517:prevention & control; D014626:Vaginal Smears / Q000379:methods*; D002578:Uterine Cervical Dysplasia / Q000473:pathology* / Q000517:prevention & control